by John Conrad | Apr 16, 2025 | Policy News
iBIO recognizes the significance of the Trump Administration’s recent Executive Order addressing drug pricing in the United States. We particularly welcome the Administration’s acknowledgment of the “pill penalty” issue and examination of PBM...
by John Conrad | Sep 12, 2024 | Policy News
In a recent hearing, the Health Care Availability & Accessibility Committee delved into the complex world of Pharmacy Benefit Managers (PBMs) and specialty pharmacies, exposing a web of concerns affecting patient care and drug pricing. The hearing, which brought...
by John Conrad | Jul 9, 2024 | Policy News
The Federal Trade Commission (FTC) has released an interim report shedding light on the practices of pharmacy benefit managers (PBMs), the middlemen in the prescription drug supply chain. The report, part of an ongoing inquiry launched in 2022, raises significant...
by John Conrad | Sep 2, 2019 | Policy News
Governor J.B. Pritzker signed HB 465 regulating Pharmacy Benefit Managers (PBMs), which are businesses that negotiate prices between drug manufacturers and pharmacies on behalf of insurance companies. Falling under the Illinois Department of Insurance, the new PBM...
